Zizhen Gong

Title: Zizhen Gong: Innovator in Tumor-Infiltrating Lymphocyte Expansion

Introduction

Zizhen Gong is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer research, particularly in the area of tumor-infiltrating lymphocytes (TILs). His innovative methods have the potential to enhance cancer treatment by improving the availability of TILs for therapeutic use.

Latest Patents

Zizhen Gong holds a patent for "Methods for preparing tumor-infiltrating lymphocytes." This patent describes methods for expanding TILs, which include co-culturing an initial cell population containing TILs with first feeder cells to obtain a first expanded cell population. Subsequently, the first expanded cell population is co-cultured with second feeder cells to obtain an expanded TIL population. These methods can quickly produce a large number of TILs from a small tumor sample, which is crucial for effective cancer therapies. He has 1 patent to his name.

Career Highlights

Zizhen Gong is associated with Shanghai Abelzeta Ltd., where he continues to work on advancing cancer treatment methodologies. His research focuses on enhancing the efficacy of TILs, which are vital for immunotherapy approaches in oncology.

Collaborations

Zizhen Gong collaborates with notable colleagues, including Jia Li and Jiyan Hou. Their combined expertise contributes to the innovative research and development efforts at Shanghai Abelzeta Ltd.

Conclusion

Zizhen Gong's work in expanding tumor-infiltrating lymphocytes represents a significant advancement in cancer treatment methodologies. His innovative approaches have the potential to improve patient outcomes and further the field of immunotherapy.